BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34596870)

  • 1. Production and Use of Gesicles for Nucleic Acid Delivery.
    Mangion M; Robert MA; Slivac I; Gilbert R; Gaillet B
    Mol Biotechnol; 2022 Mar; 64(3):278-292. PubMed ID: 34596870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved Manufacturing Methods of Extracellular Vesicles Pseudotyped with the Vesicular Stomatitis Virus Glycoprotein.
    Champeil J; Mangion M; Gilbert R; Gaillet B
    Mol Biotechnol; 2024 May; 66(5):1116-1131. PubMed ID: 38182864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudotyping exosomes for enhanced protein delivery in mammalian cells.
    Meyer C; Losacco J; Stickney Z; Li L; Marriott G; Lu B
    Int J Nanomedicine; 2017; 12():3153-3170. PubMed ID: 28458537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusogenic activity of vesicular stomatitis virus glycoprotein plasmid in tumors as an enhancer of IL-12 gene therapy.
    Eslahi NK; Muller S; Nguyen L; Wilson E; Thull N; Rolland A; Pericle F
    Cancer Gene Ther; 2001 Jan; 8(1):55-62. PubMed ID: 11219494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein transfer into human cells by VSV-G-induced nanovesicles.
    Mangeot PE; Dollet S; Girard M; Ciancia C; Joly S; Peschanski M; Lotteau V
    Mol Ther; 2011 Sep; 19(9):1656-66. PubMed ID: 21750535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vesicular stomatitis virus glycoprotein: a transducing coat for SFV-based RNA vectors.
    Dorange F; Piver E; Bru T; Collin C; Roingeard P; Pagès JC
    J Gene Med; 2004 Sep; 6(9):1014-22. PubMed ID: 15352074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transduction efficiency of pantropic retroviral vectors is controlled by the envelope plasmid to vector plasmid ratio.
    Chen Y; Miller WM; Aiyar A
    Biotechnol Prog; 2005; 21(1):274-82. PubMed ID: 15903266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VSV-G envelope glycoprotein forms complexes with plasmid DNA and MLV retrovirus-like particles in cell-free conditions and enhances DNA transfection.
    Okimoto T; Friedmann T; Miyanohara A
    Mol Ther; 2001 Sep; 4(3):232-8. PubMed ID: 11545614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel PEI/Poly-γ-Gutamic Acid Nanoparticles for High Efficient siRNA and Plasmid DNA Co-Delivery.
    Peng SF; Hsu HK; Lin CC; Cheng YM; Hsu KH
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28054985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic analysis of secretory protein traffic and characterization of golgi to plasma membrane transport intermediates in living cells.
    Hirschberg K; Miller CM; Ellenberg J; Presley JF; Siggia ED; Phair RD; Lippincott-Schwartz J
    J Cell Biol; 1998 Dec; 143(6):1485-503. PubMed ID: 9852146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved transduction efficiency of a lentiviral vector for neuron-specific retrograde gene transfer by optimizing the junction of fusion envelope glycoprotein.
    Kato S; Kobayashi K; Kobayashi K
    J Neurosci Methods; 2014 Apr; 227():151-8. PubMed ID: 24613797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-linked polyethylenimine-hexametaphosphate nanoparticles to deliver nucleic acids therapeutics.
    Patnaik S; Arif M; Pathak A; Kurupati R; Singh Y; Gupta KC
    Nanomedicine; 2010 Apr; 6(2):344-54. PubMed ID: 19699318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gellan gum blended PEI nanocomposites as gene delivery agents: evidences from in vitro and in vivo studies.
    Goyal R; Tripathi SK; Tyagi S; Ravi Ram K; Ansari KM; Shukla Y; Kar Chowdhuri D; Kumar P; Gupta KC
    Eur J Pharm Biopharm; 2011 Sep; 79(1):3-14. PubMed ID: 21272636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells.
    Mochizuki H; Schwartz JP; Tanaka K; Brady RO; Reiser J
    J Virol; 1998 Nov; 72(11):8873-83. PubMed ID: 9765432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyethylenimine-polyacrylic acid nanocomposites: Type of bonding does influence the gene transfer efficacy and cytotoxicity.
    Tripathi SK; Ahmadi Z; Gupta KC; Kumar P
    Colloids Surf B Biointerfaces; 2016 Apr; 140():117-120. PubMed ID: 26745638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled cytoplasmic and nuclear localization of plasmid DNA and siRNA by differentially tailored polyethylenimine.
    Shim MS; Kwon YJ
    J Control Release; 2009 Feb; 133(3):206-13. PubMed ID: 18992289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limiting factors governing protein expression following polyethylenimine-mediated gene transfer in HEK293-EBNA1 cells.
    Carpentier E; Paris S; Kamen AA; Durocher Y
    J Biotechnol; 2007 Feb; 128(2):268-80. PubMed ID: 17118475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic Inhibition of Human Carcinoma Cell Growth
    Weecharangsan W; Opanasopit P; Niyomtham N; Yingyongnarongkul BE; Kewsuwan P; Lee RJ
    Anticancer Res; 2017 Nov; 37(11):6335-6340. PubMed ID: 29061817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of vesicular stomatitis virus-G (VSV-G) conjugate and its use in gene transfer.
    Miyanohara A
    Cold Spring Harb Protoc; 2012 Apr; 2012(4):453-6. PubMed ID: 22474657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,4-Butanediol diglycidyl ether (BDE)-crosslinked PEI-g-imidazole nanoparticles as nucleic acid-carriers in vitro and in vivo.
    Goyal R; Bansal R; Tyagi S; Shukla Y; Kumar P; Gupta KC
    Mol Biosyst; 2011 Jun; 7(6):2055-65. PubMed ID: 21505659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.